Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Gastroenterology

Managing Complications and Long-Term Monitoring

At a Glance

Managing chronic intestinal failure (CIF) on home parenteral nutrition requires strict monitoring to prevent complications like liver disease, bloodstream infections, and bone loss. Key strategies include using fish-oil lipid emulsions, antimicrobial catheter locks, and routine lab testing.

Living with Chronic Intestinal Failure (CIF) requires a shift from short-term recovery to long-term vigilance. Because Home Parenteral Nutrition (HPN) bypasses your digestive system and connects directly to your bloodstream, it requires careful monitoring to prevent complications that can affect your liver, bones, and veins.

Protecting Your Liver: Managing IFALD

Intestinal Failure-Associated Liver Disease (IFALD) is a condition where the liver becomes stressed or damaged due to long-term IV nutrition [1]. It is often caused by a combination of things: the lack of food moving through the gut, recurrent infections, and the specific types of fats (lipids) used in HPN [1][2].

  • The Power of Fish Oil: Traditional lipid emulsions were made from soybean oil, which can be pro-inflammatory for some patients. Modern fish oil-based lipid emulsions (FOLE) have been shown to be much gentler on the liver and can even help reverse liver damage (cholestasis) in many patients [3][4].
  • Cycling HPN: Instead of running your nutrition for 24 hours, your team may “cycle” it—running it for 12 to 15 hours at night. This gives your liver a “break” and helps prevent the buildup of fats in liver cells [5][6].

Preventing Infections: The Role of Lock Solutions

Catheter-Related Bloodstream Infections (CRBSI) are one of the most serious risks for anyone with a central line [7]. An infection in your line can quickly spread to your blood, making you very ill.

To prevent this, specialized centers often use taurolidine-citrate lock solutions [8]. After you finish your infusion, a small amount of this solution is placed in the catheter to sit (or “lock”) until your next use. Unlike standard saline or heparin, taurolidine is a powerful antimicrobial that prevents bacteria and fungi from forming a “biofilm” (a protective slimy layer) inside your catheter [9][10]. Research shows these locks are significantly more effective at preventing infections than older methods [11][12].

Watching Bone and Vein Health

Two other long-term concerns require regular check-ins:

  • Metabolic Bone Disease: Patients on long-term HPN are at higher risk for osteoporosis (weak bones) [13]. This happens because the body’s balance of calcium and vitamin D is harder to maintain through a catheter. Regular DEXA scans (a type of bone density X-ray) are used to monitor bone health [14][7].
  • Central Venous Occlusion: Over years of HPN, the veins used for catheters can sometimes narrow or develop clots (thrombosis) [15]. Protecting your “vascular real estate”—the healthy veins you have left—is a critical part of your long-term care plan [16][17].

Your Monitoring Roadmap

A specialized multidisciplinary team will set a schedule tailored to you, but a typical long-term monitoring plan often includes:

Frequency What is Monitored
Weekly to Monthly Full Blood Count & Chemistry: Checking electrolytes, kidney function, and liver enzymes (ALT, AST, Bilirubin) [7][18].
Every 3-6 Months Trace Elements & Vitamins: Checking levels of zinc, copper, selenium, and vitamins (like A, D, and E) [19][7].
Annually Bone Density (DEXA): Assessing for signs of bone thinning or osteoporosis [13][14].
As Needed Vascular Imaging: Ultrasounds or “linograms” to ensure veins remain open and healthy [15].

By staying consistent with these checks, you and your team can catch small changes before they become serious complications, keeping your “lifeline” safe and effective. It’s vital that you build a care team equipped to perform this complex monitoring, as explained in Living with CIF: Building Your Care Team and Journey.

Common questions in this guide

How can I protect my liver while on long-term home parenteral nutrition?
You can protect your liver by using modern fish oil-based lipid emulsions instead of traditional soybean oil, which can be pro-inflammatory. Cycling your nutrition to run for 12 to 15 hours at night also gives your liver a break and helps prevent fat buildup in the cells.
What is a taurolidine-citrate lock solution and why is it used?
A taurolidine-citrate lock is a powerful antimicrobial solution placed inside your central line catheter between infusions. It prevents bacteria and fungi from forming a protective slimy layer, significantly reducing the risk of dangerous bloodstream infections.
Why do I need bone density scans if I have chronic intestinal failure?
Long-term home parenteral nutrition makes it harder for your body to maintain the right balance of calcium and vitamin D, increasing your risk for osteoporosis. Regular DEXA scans help your care team monitor your bone strength and catch any signs of bone thinning early.
What routine blood tests do I need to monitor my CIF?
Your care team will typically run full blood counts and chemistry panels weekly to monthly to check electrolytes, kidney function, and liver enzymes. Every three to six months, they will also test your levels of trace elements like zinc and copper, as well as essential vitamins.
Why do I need my veins monitored while on HPN?
Long-term central line use can cause veins to narrow or develop blood clots, a condition known as thrombosis. Your care team will monitor your vascular health with regular check-ins and may use imaging like ultrasounds to ensure your veins remain open and healthy.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What type of lipid emulsion is in my HPN formula, and is a fish oil-based lipid an option to protect my liver?
  2. 2.Are we using a taurolidine-citrate lock solution to prevent catheter infections? If not, why?
  3. 3.When was my last DEXA scan to check my bone density, and how often should we repeat it?
  4. 4.Have we checked the health of my veins recently to ensure we aren't at risk of central venous occlusion?
  5. 5.Can we review my most recent trace element levels, specifically zinc and copper, to see if my dose needs adjustment?
  6. 6.How often should we be doing full blood panels, and what specific liver markers are you watching most closely?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    Hepatobiliary Complications of Chronic Intestinal Failure.

    Van Gossum A, Demetter P

    Gastroenterology clinics of North America 2019; (48(4)):551-564 doi:10.1016/j.gtc.2019.08.008.

    PMID: 31668182
  2. 2

    The hepatobiliary complications of malnutrition and nutritional support in adults.

    McNeice A, Scott R, Rafferty GP, et al.

    Irish journal of medical science 2019; (188(1)):109-117 doi:10.1007/s11845-018-1836-8.

    PMID: 29850987
  3. 3

    Fish Oil Emulsion Reduces Liver Injury and Liver Transplantation in Children with Intestinal Failure-Associated Liver Disease: A Multicenter Integrated Study.

    Gura KM, Premkumar MH, Calkins KL, Puder M

    The Journal of pediatrics 2021; (230()):46-54.e2 doi:10.1016/j.jpeds.2020.09.068.

    PMID: 33038344
  4. 4

    Use of Intravenous Soybean and Fish Oil Emulsions in Pediatric Intestinal Failure-Associated Liver Disease: A Multicenter Integrated Analysis Report on Extrahepatic Adverse Events.

    Gura KM, Calkins KL, Premkumar MH, Puder M

    The Journal of pediatrics 2022; (241()):173-180.e1 doi:10.1016/j.jpeds.2021.10.030.

    PMID: 34695449
  5. 5

    Cyclic infusion mitigates liver dysfunction associated with continuous total parenteral nutrition in a novel murine model.

    Willis NB, Mims TS, Antunes K, et al.

    American journal of physiology. Gastrointestinal and liver physiology 2025; (329(4)):G536-G545 doi:10.1152/ajpgi.00033.2025.

    PMID: 40789651
  6. 6

    New Insights Into Intestinal Failure-Associated Liver Disease in Children.

    Khalaf RT, Sokol RJ

    Hepatology (Baltimore, Md.) 2020; (71(4)):1486-1498 doi:10.1002/hep.31152.

    PMID: 32003009
  7. 7

    ESPEN practical guideline: Clinical nutrition in chronic intestinal failure.

    Cuerda C, Pironi L, Arends J, et al.

    Clinical nutrition (Edinburgh, Scotland) 2021; (40(9)):5196-5220 doi:10.1016/j.clnu.2021.07.002.

    PMID: 34479179
  8. 8

    Taurolidine-Citrate Line Locks Prevent Recurrent Central Line-Associated Bloodstream Infection in Pediatric Patients.

    Clark JE, Graham N, Kleidon T, Ullman A

    The Pediatric infectious disease journal 2019; (38(1)):e16-e18 doi:10.1097/INF.0000000000002191.

    PMID: 30204661
  9. 9

    [Taurolidine, an antiseptic for the prevention of central venous catheter-related infections].

    Haro C

    Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia 2019; (36(4)):414-420 doi:10.4067/S0716-10182019000400414.

    PMID: 31859763
  10. 10

    Impact of locking solutions on conditioning biofilm formation in tunnelled haemodialysis catheters and inflammatory response activation.

    Jiménez Hernández M, Soriano A, Filella X, et al.

    The journal of vascular access 2021; (22(3)):370-379 doi:10.1177/1129729820942040.

    PMID: 32691665
  11. 11

    Taurolidine-citrate-heparin lock reduces catheter-related bloodstream infections in intestinal failure patients dependent on home parenteral support: a randomized, placebo-controlled trial.

    Tribler S, Brandt CF, Petersen AH, et al.

    The American journal of clinical nutrition 2017; (106(3)):839-848 doi:10.3945/ajcn.117.158964.

    PMID: 28793993
  12. 12

    Meta-analysis of the efficacy of taurolidine in reducing catheter-related bloodstream infections for patients receiving parenteral nutrition.

    Vernon-Roberts A, Lopez RN, Frampton CM, Day AS

    JPEN. Journal of parenteral and enteral nutrition 2022; (46(7)):1535-1552 doi:10.1002/jpen.2363.

    PMID: 35233792
  13. 13

    Osteoporosis and Hepatic Steatosis: 2 Closely Related Complications in Short-Bowel Syndrome.

    Parreiras-E-Silva LT, de Araújo IM, Elias J, et al.

    JPEN. Journal of parenteral and enteral nutrition 2020; (44(7)):1271-1279 doi:10.1002/jpen.1802.

    PMID: 32048748
  14. 14

    Longitudinal Bone Mineralization Assessment in Children Treated With Long-Term Parenteral Nutrition for Severe Intestinal Failure.

    Poinsot P, Geoffroy P, Braillon P, et al.

    JPEN. Journal of parenteral and enteral nutrition 2018; (42(3)):613-622 doi:10.1177/0148607117701399.

    PMID: 28355492
  15. 15

    Management of Central Venous Catheters in Children and Adults on Home Parenteral Nutrition: A French Survey of Current Practice.

    Gotchac J, Poullenot F, Guimber D, et al.

    Nutrients 2022; (14(12)) doi:10.3390/nu14122532.

    PMID: 35745262
  16. 16

    Central line-associated bloodstream infections and complications in adult home parenteral nutrition: Observations from a quality improvement initiative.

    Fessler TA, Crandall MB, Schumacher SE, Martin DN

    Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition 2025; (40(6)):1612-1628 doi:10.1002/ncp.11338.

    PMID: 40583336
  17. 17

    Home parenteral nutrition-associated thromboembolic and bleeding events: results of a cohort study of 236 individuals.

    Barco S, Heuschen CB, Salman B, et al.

    Journal of thrombosis and haemostasis : JTH 2016; (14(7)):1364-73 doi:10.1111/jth.13351.

    PMID: 27122107
  18. 18

    Imaging of adult intestinal failure.

    Smith J, Godfrey E, Bowden D, et al.

    Clinical radiology 2019; (74(8)):603-612 doi:10.1016/j.crad.2018.12.007.

    PMID: 30654907
  19. 19

    Antioxidant trace elements serum levels in long-term parenteral nutrition (PN): Prevalence and infectious risk associated with deficiencies, a retrospective study from a tertiary home-PN center.

    Uzzan M, Kirchgesner J, Poupon J, et al.

    Clinical nutrition (Edinburgh, Scotland) 2017; (36(3)):812-817 doi:10.1016/j.clnu.2016.05.008.

    PMID: 27245643

This page provides educational information about managing chronic intestinal failure and HPN complications. Always consult your multidisciplinary healthcare team for personalized monitoring, catheter care, and treatment decisions.

Get notified when new evidence is published on Chronic intestinal failure.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.